Article
Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
The Journal of molecular diagnostics : JMD - 1 Apr 2021
Jiang Liqun, Pallavajjala Aparna, Huang Jialing, Haley Lisa, Morsberger Laura, Stinnett Victoria, Hardy Melanie, Park Rebecca, Ament Candice, Finch Alexandra, Shane Alison, Parish Rebecca, Nozari Azin, Long Patty, Adams Emily, Smith Kirstin, Parimi Vamsi, Dougaparsad Sam, Long Lori, Gocke Christopher D, Zou Ying S
Abstract excerpt
Copy number variants (CNVs) and gene mutations are important for diagnosis and treatment of myeloid malignancies. In a routine clinical setting, somatic gene mutations are detected by targeted next-generation sequencing (NGS) assay, but CNVs are commonly detected by conventional chromosome analysis and fluorescence in situ hybridization (FISH). The aim of this proof-of-principle study was to investigate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
